Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38

Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38

US Patent 11021543 · Granted Jun 1, 2021

Estimated economic value: $144,078,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Bispecific antibodies against CD3 and CD202025
Anti-CD38 antibodies for treatment of acute myeloid leukemia2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-pos2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Methods of treating cancers and enhancing efficacy of T cell redirecting therape2024
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leuk2024
Bispecific antibody against CD3 and CD20 in combination therapy for treating dif2023
Methods of treating high risk multiple myeloma2023
Methods of treating high risk multiple myeloma2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating fol2023